Verrica Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.462; its P/E ratio is -3.86; Verrica Pharmaceuticals is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 2.92M	$ 182.00K	$ 37.00K	$ 68.00K	$ 8.32M
Gross Profit	$ 2.92M	$ 182.00K	$ 37.00K	$ 68.00K	-
EBIT	$ -22.61M	$ -10.72M	$ -7.09M	$ -6.28M	$ 164.00K
EBITDA	-	$ -10.51M	$ -6.89M	$ -6.06M	$ 291.00K
Net Income Common Stockholders	$ -24.26M	$ -10.99M	$ -6.59M	$ -5.93M	$ 83.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 84.30M	$ 55.10M	$ 60.00M	$ 34.30M	$ 39.45M
Total Assets	$ 97.15M	$ 62.16M	$ 68.64M	$ 44.72M	$ 49.15M
Total Debt	$ 43.82M	$ 1.38M	$ 1.45M	$ 1.53M	$ 1.59M
Net Debt	$ -40.48M	$ -53.72M	$ -58.55M	$ -32.77M	$ -37.86M
Total Liabilities	$ 54.84M	$ 6.80M	$ 3.79M	$ 4.69M	$ 4.38M
Stockholders Equity	$ 42.30M	$ 55.43M	$ 64.85M	$ 40.03M	$ 44.77M
Cash Flow	-
Free Cash Flow	-	$ -4.73M	$ -4.60M	$ -5.02M	$ 1.75M
Operating Cash Flow	$ -14.81M	$ -4.67M	$ -4.59M	$ -4.95M	$ 1.82M
Investing Cash Flow	$ -65.00K	$ -59.00K	$ -11.00K	$ 6.75M	$ 2.07M
Financing Cash Flow	$ 44.04M	$ -84.00K	$ 30.28M	-	$ -16.85M

Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

Income Statement >

Verrica Pharmaceuticals Debt to Assets

Balance Sheet >

Verrica Pharmaceuticals Cash Flow

Cash Flow >

Verrica Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing